加载中...
广告
| 发布时间 | 所属地区 | 所属机构 | 语言 |
|---|---|---|---|
| 2025年03月05日 | -- | -- | 英语 (English) 中文 |
Published date: 5 March 2025
Open opportunity - This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.
Pharmacy services - 85149000
NW1 2PB
£81,600 to £816,000
CF-2881000D0O000000rwimUAA
5 March 2025
26 March 2025
12pm
3 November 2025
2 November 2027
Service contract
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
No
No
The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.
Additional text
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk
Follow the instructions given in the description or the more information section.
Aaron Monaghan
179a Tottenham Court Road
London
NW1 2PB
GB
Is there anything wrong with this page?
猜你喜欢
加载中...
广告
招标网APP
微信服务号
